FDA Adverse Event Malfunction Summary report: N

ID NOW COVID-19 ASSAY

MDR report key: 11566532 · Received March 24, 2021

Report

Report Number
1221359-2021-00769
Event Type
Malfunction
Date Received
March 24, 2021
Report Date
June 4, 2021
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QJR
UDI-DI
10811877011269
PMA / PMN Number
EUA2000074
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

REFERENCE REPORTS: 1221359-2021-00771. THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.

Additional Manufacturer Narrative · 1

TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS (B)(4), INC. ON RETAINED KIT LOT M141384 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 190- 000 / LOT M141384, TEST BASE PART NUMBER 190-430 / LOT M141384. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 1018106 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS (B)(4) WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER IT COULD POSSIBLY BE RELATED TO THE SPECIFIC PATIENT SAMPLES OR CROSS CONTAMINATION.

Description of Event or Problem · 1

A CUSTOMER SENT A CUMULATIVE REPORT OF FIVE FALSE POSITIVE RESULTS INVOLVING THREE LOT NUMBERS WITH THE ID NOW COVID-19 ASSAY GENERATED ACROSS FIVE DIFFERENT TESTING SITES. THIS REPORT REPRESENTS LOT NUMBER M141384. THIS IS REPORT ONE OF THREE. THE CUSTOMER REPORTED TWO FALSE POSITIVE RESULTS USING A NASAL SWAB WITH THE ID NOW COVID-19 TEST. SPECIMEN COLLECTION OCCURRED ON (B)(6) 2021 AND (B)(6) 2021 RESPECTIVELY; TESTING DATE AND TIME IS UNKNOWN. CONFIRMATION TESTING WAS PERFORMED ON A NASOPHARYNGEAL SWAB IN VIRAL TRANSPORT MEDIA WITH (B)(6) LAB PROVIDED NEGATIVE RESULTS. CONFIRMATORY SPECIMEN COLLECTION OCCURRED ON (B)(6) 2021 AND (B)(6) 2021. PER THE CUSTOMER, ADDITIONAL PATIENT INFORMATION, INCLUDING SYMPTOMS, TREATMENT AND OUTCOME, IS UNKNOWN. NO ADDITIONAL INFORMATION WILL BE PROVIDED. POSITIVE RESULTS ARE INDICATIVE OF THE PRESENCE OF SARS-COV-2 RNA; CLINICAL CORRELATION WITH PATIENT HISTORY AND OTHER DIAGNOSTIC INFORMATION IS NECESSARY TO DETERMINE PATIENT INFECTION STATUS. POSITIVE RESULTS DO NOT RULE OUT BACTERIAL INFECTION OR CO-INFECTION WITH OTHER VIRUSES. DUE TO THE HIGH SENSITIVITY OF THE ASSAYS RUN ON THE INSTRUMENT, CONTAMINATION OF THE WORK AREA WITH PREVIOUS POSITIVE SAMPLES MAY CAUSE FALSE POSITIVE RESULTS. HANDLE SAMPLES ACCORDING TO STANDARD LABORATORY PRACTICES. CLEAN INSTRUMENTS AND SURROUNDING SURFACES ACCORDING TO INSTRUCTIONS PROVIDED IN THE CLEANING SECTION OF THE INSTRUMENT USER MANUAL. DUE TO THE RISK OF A FALSE POSITIVE RESULT LEADING TO POSSIBLE EXPOSURE TO COVID-19 THROUGH THE QUARANTINE OF THE FALSE POSITIVE PATIENT WITH TRUE POSITIVE PATIENT(S), DELAYED EMERGENCY TREATMENT AND/OR INAPPROPRIATE TREATMENT WITH ANTIVIRAL THERAPY, THE INCIDENT SHALL BE CONSIDERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
456194 ID NOW COVID-19 ASSAY MOLECULAR IVD FOR ID NOW COVID-19 QJR ABBOTT DIAGNOSTICS SCARBOROUGH, INC. M141384 10811877011269

Patients

Seq Age Sex Outcome Treatment
1